Cargando...
Bortezomib may Stabilize Pediatric Renal Transplant Recipients with Antibody-Mediated Rejection
BACKGROUND: Current therapeutic strategies to effectively treat antibody-mediated rejection (AMR) are insufficient. Thus, we aimed to determine the benefit of a therapeutic protocol using bortezomib for refractory C4d+ AMR in pediatric kidney transplant patients. METHODS: We examined 7 patients with...
Guardado en:
| Publicado en: | Pediatr Nephrol |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590841/ https://ncbi.nlm.nih.gov/pubmed/27048228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-016-3319-3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|